Oriens (Dimenhydrinate)

Dimenhydrinate, the active ingredient in Oriens, is a first‑generation antihistamine presented as an oral tablet for oral use. It is employed to prevent and treat nausea, vomiting, and dizziness associated with motion sickness, vertigo, and postoperative conditions in adults and children.

GNH USA supplies Oriens as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality, regulatory compliance, and reliable logistics for global healthcare partners through robust quality‑assurance processes and timely delivery across multiple continents.

Dimenhydrinate is an H1‑antihistamine used to manage vestibular‑related nausea and dizziness.

Motion sickness: reduces nausea, vomiting and dizziness caused by travel or movement. Vertigo: alleviates dizziness associated with vestibular disorders. Post‑operative nausea: helps prevent nausea and vomiting after surgical procedures.

Common Side Effects: - Drowsiness - Dry mouth - Blurred vision - Constipation - Headache - Urinary retention

Serious or Rare Side Effects: - Cardiac arrhythmia - Severe allergic reaction (anaphylaxis) - Seizures - Hallucinations - Persistent dizziness - Severe skin reactions such as Stevens‑Johnson syndrome

Precautions for dimenhydrinate include careful assessment of patient-specific risk factors. - Glaucoma: avoid in patients with narrow‑angle glaucoma. - Urinary retention: use cautiously in individuals with prostate enlargement. - Sedation: advise patients not to operate machinery while experiencing drowsiness. - Elderly: monitor closely due to increased fall risk. - Hypersensitivity: contraindicated in patients with known allergy to dimenhydrinate or related antihistamines. - Store at room temperature: keep in original container, protect from moisture and heat.

Dimenhydrinate may interact with several drug classes.

Major Interactions (Avoid): - Alcohol: additive central nervous system depression. - CNS depressants (benzodiazepines, opioids): increased sedation and respiratory depression. - Anticholinergic agents: heightened anticholinergic side effects.

Moderate Interactions (Monitor Closely):\n- Antihypertensives: possible additive hypotensive effect. - Tricyclic antidepressants: increased anticholinergic burden. - Antacids: may affect absorption of dimenhydrinate.